Opioid Treatment Program Forms
To prescribe under the NSW Opioid Treatment Program (OTP), key forms are required to provide patient entry into treatment, exit from treatment, and to notify changes in dosing points.
This application form is used to apply for approval* to enter a patient into the NSW OTP, and must be completed by the prescriber. Approval* to prescribe methadone or buprenorphine (including buprenorphine-naloxone) must be granted by the Ministry of Health before a prescription may be issued to commence treatment.
This form should also be used if changing pharmacotherapies that a patient is prescribed (i.e., between methadone and buprenorphine preparations, or vice versa).
Patients must be formally exited from treatment by completing and submitting this form for each patient discharged from treatment.
This form should also be used for a patient that is transferred from the care of one prescriber to another. Unit this form is submitted, the new prescriber will be unable to commence treatment for the patient.
If a NSW OTP patient is permanently changing their dosing point, this form should be used to notify the Ministry of Health, Pharmaceutical Services Unit.
*Terminology has been updated from ‘authorities’ to ‘approvals’ to distinguish it from Commonwealth PBS authorities. In SafeScript NSW, an approval is a reference to an authority issued under the Poisons and Therapeutic Goods Act 1966.